Lucid Diagnostics (LUCD) Accounts Payables (2020 - 2026)

Lucid Diagnostics has reported Accounts Payables for 7 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 48.05% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 48.05% YoY), and the FY2025 full-year result was $970000.0, down 21.84% from the prior year.
• Accounts Payables for Q1 2026 stood at $1.1 million, up from $970000.0 in the prior quarter.
• The five-year high for Accounts Payables was $9.3 million in Q4 2023, with the low at $625000.0 in Q1 2023.
• Historically, Accounts Payables has averaged $2.3 million across 5 years, with a median of $2.0 million in 2024.
• Annual changes were most pronounced in 2023 — Accounts Payables jumped 545.4% — and 2024, when it sank 86.71%.
• Lucid Diagnostics' Accounts Payables stood at $1.4 million in 2022, then jumped by 545.4% to $9.3 million in 2023, then slumped by 86.71% to $1.2 million in 2024, then decreased by 21.84% to $970000.0 in 2025, then advanced by 11.03% to $1.1 million in 2026.
• The last three Accounts Payables figures came in at $1.1 million (Q1 2026), $970000.0 (Q4 2025), and $751000.0 (Q3 2025), per Business Quant data.